Purpose–The study aims to explore the interplay between open innovation and intellectual property.Differently from previous studies, we argue that open innovation fosters firm’s patenting activity.Design/methodology/approach–We use linear regression analysis to test model’s hypotheses. Data aredrawn from the Eurostat statistics and refer to a large sample of European firms (NACE Rev.2).Findings–The findings confirm that open innovation fosters patenting activity in health care, also thanks tohuge governments’expenditures in this market.Research limitations/implications–The study focuses solely on European firms and it adopts atraditional linear approach. So, we cannot exclude that different dynamics may occur across European borders.Future research should address this concern by focusing on multi-country comparative studies.Practicalimplications–Open innovation is the most suitable model for health industry, because it improvesboth innovation performance and intellectual capital of firms.Originality/value–The study tackles an existing gap of the literature by considering how the presence oflarge customers impacts the strength of intellectual property protection
Open innovation and patenting activity in health care
Beatrice Orlando
Primo
;Francesco CiampiUltimo
2021
Abstract
Purpose–The study aims to explore the interplay between open innovation and intellectual property.Differently from previous studies, we argue that open innovation fosters firm’s patenting activity.Design/methodology/approach–We use linear regression analysis to test model’s hypotheses. Data aredrawn from the Eurostat statistics and refer to a large sample of European firms (NACE Rev.2).Findings–The findings confirm that open innovation fosters patenting activity in health care, also thanks tohuge governments’expenditures in this market.Research limitations/implications–The study focuses solely on European firms and it adopts atraditional linear approach. So, we cannot exclude that different dynamics may occur across European borders.Future research should address this concern by focusing on multi-country comparative studies.Practicalimplications–Open innovation is the most suitable model for health industry, because it improvesboth innovation performance and intellectual capital of firms.Originality/value–The study tackles an existing gap of the literature by considering how the presence oflarge customers impacts the strength of intellectual property protectionFile | Dimensione | Formato | |
---|---|---|---|
10-1108_JIC-03-2020-0076 Open innovation and patenting.pdf
accesso aperto
Descrizione: Post-print
Tipologia:
Post-print
Licenza:
PUBBLICO - Pubblico con Copyright
Dimensione
275.94 kB
Formato
Adobe PDF
|
275.94 kB | Adobe PDF | Visualizza/Apri |
10-1108_JIC-03-2020-0076.pdf
solo gestori archivio
Descrizione: Full text editoriale
Tipologia:
Full text (versione editoriale)
Licenza:
NON PUBBLICO - Accesso privato/ristretto
Dimensione
276.67 kB
Formato
Adobe PDF
|
276.67 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.